Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme

NCT01800695 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: ABT-414
DRUG: Temozolomide
RADIATION: Whole Brain Radiation

Sponsor

AbbVie